Events & Presentations

Upcoming Events
Date Event Details Remind Me
Apr 3 - Apr 4, 2023
7th Complement UK Training Course and Symposium
Archived Events
Date Event Details
Sep 14, 2022 3:30 PM EDT
Morgan Stanley 20th Annual Global Healthcare Conference

Note: Presentation Cancelled

Type: Fireside chat presentation
Presenter: Christopher Anzalone, Ph.D., President and CEO, Arrowhead Pharmaceuticals

Sep 13, 2022 4:20 PM EDT
Baird 2022 Global Healthcare Conference
Type: Fireside chat presentation
Presenter: Christopher Anzalone, Ph.D., President and CEO, Arrowhead Pharmaceuticals
Sep 12 - Sep 14, 2022
H.C. Wainwright 24th Annual Global Investment Conference – September 12-14, 2022
Type: Fireside chat presentation
Presenter: Christopher Anzalone, Ph.D., President and CEO, Arrowhead Pharmaceuticals
Sep 7 - Sep 9, 2022
2022 Wells Fargo Healthcare Conference
Type: Investor meetings
Presenter: Vincent Anzalone, CFA, Vice President Finance and Investor Relations, Arrowhead Pharmaceuticals
Sep 4 - Sep 6, 2022
European Respiratory Society (ERS) International Congress 2022

Title: Silencing MMP7 expression with a lung-targeted RNAi molecule limits fibrosis and preserves pulmonary function in bleomycin-injured rats
Presenter: Erik Bush, Ph.D., Group Vice President, Biology, Arrowhead Pharmaceuticals

Aug 4, 2022 4:30 PM EDT
Arrowhead Pharmaceuticals 2022 Third Quarter Results
Jun 22 - Jun 26, 2022
The International Liver Congress™ 2022 - The Annual Meeting of the European Association for the Study of the Liver (EASL)

Title: Effects of the siRNA JNJ-3989 and/or the Capsid Assembly Modulator JNJ-6379 on Viral Markers of Chronic Hepatitis B: Results From the REEF-1 Study
Presenter: Man-Fung Yuen, Department of Medicine & State Key Laboratory of Liver Research, Queen Mary Hospital, The University of Hong Kong

Title: Understanding the Dynamics of HBsAg Decline Through Model-informed Drug Development (MIDD) of siRNA and CAM-N for the Treatment of Chronic Hepatitis B (CHB) Virus Infection
Presenter: Huybrecht T’jollyn, Janssen Research & Development

Title: Efficacy and Safety of Finite 48-week Treatment With the siRNA JNJ-3989 and the Capsid Assembly Modulator JNJ-6379 in HBeAg Negative Virologically Suppressed Chronic Hepatitis B Patients: Results from the REEF-2 Study
Presenter: Kosh Agarwal, Institute of Liver Studies, King’s College Hospital

Title: Reduction of Intra-hepatic Z-AAT Synthesis by Fazirsiran Decreases Globule Burden and Improves Histological Measures of Liver Disease in Adults with Alpha-1 Antitrypsin Deficiency
Presenter: Pavel Strnad, Department of Internal Medicine III, University Hospital, Rwth Aachen

Jun 13 - Jun 16, 2022
Goldman Sachs 43rd Annual Global Healthcare Conference
Type: Fireside chat presentation
Presenter: Vincent Anzalone, Vice President Finance and Investor Relations, Arrowhead Pharmaceuticals
Jun 8, 2022 8:30 AM EDT
Jefferies Healthcare Conference
Type: Fireside chat presentation
Presenter: Vincent Anzalone, Vice President Finance and Investor Relations, Arrowhead Pharmaceuticals
May 26, 2022 10:00 AM EDT
Pulmonary R&D Day
New York